These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13986712)

  • 1. [Effect of GABOB (gamma-amino-beta-hydroxybutyric acid) in epilepsy with special reference to EEG-findings due to intravenous injection].
    SATO K
    Naika Hokan; 1963 Jan; 10():47-54. PubMed ID: 13986712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the clinical use of GABOB (gamma-amino-beta-hydroxybutyric acid). Administration of the drug by intravenous route. (Preliminary observations)].
    GORI EC
    G Psichiatr Neuropatol; 1962; 90():853-60. PubMed ID: 13949277
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modern orientations in the therapy of epilepsy in the light of recent acquisitions regarding cerebral metabolism of gamma-amino-butyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB)].
    DE MAIO D
    Clin Ter; 1962 Nov; 23():832-51. PubMed ID: 14025905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of gamma-amino-beta-hydroxybutyric acid (GABHB) on experimentally-induced epileptic activity].
    Chemello R; Giaretta D; Pellegrini A; Testa G
    Riv Neurol; 1980; 50(4):253-68. PubMed ID: 7466221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREATMENT OF EPILEPSY BY INTRASPINAL INJECTION OF GAMMA-AMINO-BETA-HYDROXYBUTYRIC ACID (GABOB).
    NISHIMOTO A; MORI A; TAKASHITA H; NAMBA H
    Folia Psychiatr Neurol Jpn; 1964 Feb; 17():351-7. PubMed ID: 14196973
    [No Abstract]   [Full Text] [Related]  

  • 6. An experimental electroencephalographic study of certain derivatives of "GABOB" (gamma-amino-beta-hydroxybutyric acid).
    Pinelli P
    Farmaco Sci; 1970 Mar; 25(3):187-202. PubMed ID: 5453295
    [No Abstract]   [Full Text] [Related]  

  • 7. [gamma-Aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB) in the perspective of biological anti-epilepsy therapy].
    DE MAIO D; MADEDDU A; FAGGIOLI L
    Acta Neurol (Napoli); 1961; 16():366-406. PubMed ID: 13720682
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with GABOB (gamma-amino-beta-hydroxybutyric acid) in epilepsy].
    WADA T; GOTO A; FUKUSHIMA Y
    Chiryo; 1962 Jul; 44():1415-9. PubMed ID: 14004248
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gamibetal (gamma-amino-beta-hydroxybutyric acid--GABOB) in the treatment of epilepsy].
    Grbesa B; Vasiljević P; Vlajin L
    Med Glas; 1967; 21(3):75-7. PubMed ID: 6082678
    [No Abstract]   [Full Text] [Related]  

  • 10. GABOB (gamma-amino-beta-hydroxybutyric acid) treatment in epilepsy.
    WADA T; GOTO A; FUKUSHIMA Y; TATEYAMA K
    Folia Psychiatr Neurol Jpn; 1961 Dec; 15():327-35. PubMed ID: 13998150
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth hormone release by gamma-aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB) in the rat.
    Abe H; Kato Y; Chihara K; Ohgo S; Iwasaki Y
    Endocrinol Jpn; 1977 Apr; 24(2):229-31. PubMed ID: 872825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of gamma-amino-beta-hydroxybutyric acid (GABOB) on the electroencephalogram of epileptic subjects].
    GIOVE C; DE MAIO D
    Riv Sper Freniatr Med Leg Alien Ment; 1962 Mar; 86():113-32. PubMed ID: 13898839
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the oxygen consumption of cerebral homogenates in presence of gamma-aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB)].
    Brunelli A; Ferri S; Galatulas I
    Boll Soc Ital Biol Sper; 1967 Dec; 43(23):1711-3. PubMed ID: 5626744
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic effects of gamma-aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB)].
    Maccari M; Maggi GC
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:1917-21. PubMed ID: 5875466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of gamma-amino-beta-hydroxybutyric acid in epilepsy, with special reference to its effect on brain waves].
    TADOKORO Y; HAN K; OKADA T; KANK ; HIRANO C
    Sogo Igaku; 1962 May; 19():462-5. PubMed ID: 13918892
    [No Abstract]   [Full Text] [Related]  

  • 16. [On changes in the brain waves of epileptics after peroral administration of y-amino b-hydroxybutyric acid].
    TAKASHITA H; NANBA Y
    Sogo Igaku; 1962 May; 19():452-3. PubMed ID: 13919158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gamma-amino-beta-hydroxybutyric acid in the treatment of epilepsy. Electroencephalographic findings in the course of therapy].
    Bernardi L
    Minerva Med; 1966 Dec; 57(100):4301-10. PubMed ID: 5958223
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic action of gamma-amino-beta-hydroxybutyric acid (Gabob) on chorea minor and modifications in Glanzmann's writing test during the treatment].
    Colucci D'Amato F
    Osp Psichiatr; 1965; 33(1):122-31. PubMed ID: 5865565
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies on the EEG-activating effects of Na-beta, beta-pentamethylene-gamma-hydroxybutyrate, a new central stimulant. Usefulness as a new EEG-activating agent].
    Goto Y; Kazamatsuri H; Taen S
    No To Shinkei; 1965 Sep; 17(9):879-87. PubMed ID: 4378545
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on electroencephalographic abnormalities of epileptic patients treated with GABOB].
    D'Errico A; Di Perri R
    Rass Neuropsichiatr; 1964; 18(4):370-8. PubMed ID: 5319046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.